ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,486Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 2170

$1.2M Total Retail Price of All Prescriptions

Rank: 37 out of 2170

403 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 403 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 403 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 24,278 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

66 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
WARFARIN SODIUM 2,233 2,104 1 15
OMEPRAZOLE 939 858 2 2
FUROSEMIDE 834 800 3 6
LEVOTHYROXINE SODIUM 705 688 4 5
LISINOPRIL 674 643 5 3
HYDROCODONE-ACETAMINOPHEN 643 637 S3 6 7
CITALOPRAM HBR 641 602 7 19
AMLODIPINE BESYLATE 578 516 8 4
SIMVASTATIN 548 506 9 1
GABAPENTIN 543 488 10 14
DONEPEZIL HCL 439 431 11 32
POLYETHYLENE GLYCOL 3350 419 373 12 63
LANTUS 403 382 13 51
METOPROLOL TARTRATE 384 384 14 10
COUMADIN 371 331 15 163
DIVALPROEX SODIUM 315 310 16 91
POTASSIUM CHLORIDE 313 304 17 16
NOVOLIN R 308 284 18 149
FENTANYL 296 296 S2 19 87
NAMENDA 268 268 20 48
IPRATROPIUM-ALBUTEROL 268 261 20 131
ZOLPIDEM TARTRATE 267 221 22 17
CARVEDILOL 267 242 22 26
RANITIDINE HCL 255 244 24 40
CYMBALTA 238 218 25 44
METOPROLOL SUCCINATE 234 206 26 13
GENERLAC 221 209 27 214
DIGOXIN 218 205 28 72
MIRTAZAPINE 217 195 29 46
KLOR-CON 10 215 199 30 144
PREDNISONE 212 192 31 41
KLOR-CON M20 211 182 32 68
CLOPIDOGREL 210 205 33 37
LEVETIRACETAM 186 160 34 109
CARBIDOPA-LEVODOPA 176 176 35 110
TRAMADOL HCL 176 164 35 18
OXYCODONE HCL 174 144 S2 37 56
ISOSORBIDE MONONITRATE ER 168 168 38 50
SERTRALINE HCL 167 144 39 25
LEVOFLOXACIN 165 152 40 99
MORPHINE SULFATE 162 159 S2 41 253
CIPROFLOXACIN HCL 149 143 42 69
ADVAIR DISKUS 143 143 43 45
LIDODERM 140 130 44 162
PLAVIX 139 131 45 58
LIDOCAINE 137 137 46 323
KETOCONAZOLE 133 123 47 212
QUETIAPINE FUMARATE 129 129 48 88
OXYCONTIN 128 122 S2 49 146
TAMSULOSIN HCL 126 126 50 33
METFORMIN HCL 124 103 51 8
AMOX TR-POTASSIUM CLAVULANATE 123 108 52 126
OLANZAPINE 119 119 53 139
SPIRIVA 118 116 54 49
BACLOFEN 116 64 55 137
GLIPIZIDE 112 112 56 62
TRIAMCINOLONE ACETONIDE 105 102 57 128
NYSTATIN 102 101 58 160
PROMETHAZINE HCL 98 55 R 59 70
ONDANSETRON HCL 98 97 59 230
DIOVAN 96 84 61 53
PROCRIT 95 41 62 298
DOXYCYCLINE HYCLATE 93 88 63 100
HYDRALAZINE HCL 92 78 64 84
OXYCODONE-ACETAMINOPHEN 92 81 S2 64 60
METOCLOPRAMIDE HCL 90 76 66 127
CHLORHEXIDINE GLUCONATE 90 77 66 374
PAROXETINE HCL 89 89 68 65
VOLTAREN 87 83 69 226
TRANSDERM-SCOP 86 55 70 330
PANTOPRAZOLE SODIUM 85 85 71 39
NYSTOP 84 80 72 219
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 68 73 95
CLONIDINE HCL 80 64 74 54
FLUTICASONE PROPIONATE 79 65 75 30
ESCITALOPRAM OXALATE 79 79 75 75
ATORVASTATIN CALCIUM 78 61 77 12
NOVOLIN 70-30 77 71 78 217
CEPHALEXIN 77 71 78 120
ZETIA 76 76 80 78
NITROGLYCERIN PATCH 75 75 81 232
ALBUTEROL SULFATE 75 73 81 167
LYRICA 73 73 83 90
LOSARTAN POTASSIUM 73 73 83 21
ROPINIROLE HCL 73 73 83 92
FLUCONAZOLE 72 67 86 158
AMIODARONE HCL 71 71 87 235
HYDROCHLOROTHIAZIDE 70 47 88 9
RISPERIDONE 70 67 88 73
ALENDRONATE SODIUM 66 65 90 36
HYDROXYZINE HCL 65 52 R 91 173
ENOXAPARIN SODIUM 65 54 91 341
NOVOLOG 65 62 91 98
NEXIUM 64 48 94 22
LATANOPROST 63 63 95 194
DILTIAZEM 24HR CD 62 61 96 82
MORPHINE SULFATE ER 62 62 S2 96 124
CARAFATE 61 36 98 336
SUCRALFATE 61 40 98 197
TRICOR 60 36 100 130
XARELTO 60 60 100 383
HYDROMORPHONE HCL 60 11 S2 100 309
ALLOPURINOL 59 54 103 29
TRAVATAN Z 57 57 104 181
SINGULAIR 53 48 105 85
CRESTOR 53 52 105 24
SPIRONOLACTONE 50 50 107 71
LEVEMIR 50 15 107 195
METHADOSE 50 0 S2 10 107 484
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.